%0 Journal Article
%T Neoadjuvant chemotherapy followed by minimally invasive esophagectomy is safe and feasible for treatment of esophageal squamous cell carcinoma
%A Dandan Liu
%A Jie Bai
%A Jingdi Wang
%A Jintao Song
%A Keyi Wang
%A Liang Jin
%A Shaohua Ma
%A Tiansheng Yan
%A Tong Wang
%A Wei He
%A Xiaoxin Chen
%J Archive of "Thoracic Cancer".
%D 2018
%R 10.1111/1759-7714.12590
%X The advantage of neoadjuvant chemotherapy (NAC) followed by open esophagectomy for treatment of esophageal squamous cell carcinoma has been widely recognized. However, the safety and feasibility of NAC for patients receiving minimally invasive esophagectomy (MIE) remain controversial. The purpose of this study was to evaluate the potential impact of prior neoadjuvant chemotherapy on the clinical outcome of MIE by comparing two groups of patients, MIE alone and NAC plus MIE
%K Esophageal squamous cell carcinoma
%K minimally invasive esophagectomy
%K neoadjuvant chemotherapy
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792721/